Promotion of the genipin crosslinked chitosan-fiber hydrogel loaded with sustained release of clemastine fumarate in diabetic wound repair

Int J Biol Macromol. 2023 Jan 31:226:900-914. doi: 10.1016/j.ijbiomac.2022.12.022. Epub 2022 Dec 8.

Abstract

Diabetic skin disorders are lingering and refractory clinical diseases. In this study, a genipin-crosslinked porous chitosan fiber (CSF) hydrogel was fabricated to achieve rapid wound healing. By embedding clemastine fumarate (CF) in the CSF hydrogel pores, we synthesised a CSF/CF hydrogel for the treatment of diabetic wounds. The microstructure, chemical elements, spectral variation, mechanical properties, swelling ratios, degradability, and toxicity of the CSF/CF hydrogels were studied. Compared with the typical CS power hydrogel, the porous CSF hydrogel crosslinked with genipin possesses a stable structure and improved physicochemical properties. Moreover, CF was slowly released from the CSF hydrogel. Molecular simulation also showed that CF was evenly embedded inside the cavity formed by the novel CSF hydrogel. The results suggested that CF can resist damage from high glucose levels and promote proliferation, tube formation, and migration of endothelial cells (ECs) and fibroblasts. The CSF/CF hydrogel promoted wound healing in a rat model. Mechanistically, the beneficial effect of CF on wound healing may be related to activation of the MEK/ERK and PI3K/Akt signalling pathways. In conclusion, genipin-crosslinked CSF/CF hydrogel can accelerate wound healing and may be an effective therapeutic method for treating diabetic skin lesions.

Keywords: Chitosan fiber; Clemastine fumarate; Hydrogel.

MeSH terms

  • Animals
  • Biocompatible Materials / pharmacology
  • Chitosan* / chemistry
  • Clemastine / pharmacology
  • Delayed-Action Preparations / pharmacology
  • Diabetes Mellitus*
  • Endothelial Cells
  • Hydrogels / chemistry
  • Phosphatidylinositol 3-Kinases
  • Rats
  • Wound Healing

Substances

  • Hydrogels
  • Chitosan
  • genipin
  • Clemastine
  • Phosphatidylinositol 3-Kinases
  • Delayed-Action Preparations
  • Biocompatible Materials